{"trigger": ["Mice .", "Mice ."], "relation": []}
{"trigger": ["<extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> F / F <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> - <extra_id_0> cre <extra_id_2> Protein <extra_id_1> and <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> <extra_id_0> GFP <extra_id_2> Protein <extra_id_1> mice have previously been described ( Bettelli et al . , 2006 ; Naoe et al . , 2007 ) .", "Cbfb F / F CD4 - cre and Foxp3 GFP mice have previously been described ( Bettelli et al . , 2006 ; Naoe et al . , 2007 ) ."], "relation": []}
{"trigger": ["<extra_id_0> Cd45.1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> Rag2 <extra_id_2> Protein <extra_id_1> - / - mice were purchased from Jackson ImmunoResearch Laboratories and Taconic , respectively .", "Cd45.1 and Rag2 - / - mice were purchased from Jackson ImmunoResearch Laboratories and Taconic , respectively ."], "relation": []}
{"trigger": ["For the in vivo <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> conversion assay , naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells from <extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> - <extra_id_0> cre <extra_id_2> Protein <extra_id_1> or control mice ( harboring a <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> - IRES - <extra_id_0> GFP <extra_id_2> Protein <extra_id_1> allele ) were adoptively transferred into <extra_id_0> Rag <extra_id_2> Protein <extra_id_1> - deficient mice .", "For the in vivo Foxp3 conversion assay , naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele ) were adoptively transferred into Rag - <extra_id_0> deficient <extra_id_2> Negative_regulation <extra_id_1> mice ."], "relation": [["For the in vivo Foxp3 conversion assay , naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele ) were adoptively transferred into Rag - <extra_id_0> deficient <extra_id_2> Negative_regulation <extra_id_1> mice .", "For the in vivo Foxp3 conversion assay , naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele ) were adoptively transferred into <extra_id_0> Rag <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> - deficient mice ."]]}
{"trigger": ["5 x 106 cells were used per transfer .", "5 x 106 cells were used per transfer ."], "relation": []}
{"trigger": ["6 wk later , <extra_id_0> TCRbeta <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + gated cells from the spleen , mesenteric lymph node ( MLN ) , and lamina propria of the small intestine were analyzed for <extra_id_0> Foxp3-GFP <extra_id_2> Protein <extra_id_1> expression .", "6 wk later , TCRbeta + CD4 + gated cells from the spleen , mesenteric lymph node ( MLN ) , and lamina propria of the small intestine were analyzed for Foxp3-GFP <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> ."], "relation": [["6 wk later , TCRbeta + CD4 + gated cells from the spleen , mesenteric lymph node ( MLN ) , and lamina propria of the small intestine were analyzed for Foxp3-GFP <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> .", "6 wk later , TCRbeta + CD4 + gated cells from the spleen , mesenteric lymph node ( MLN ) , and lamina propria of the small intestine were analyzed for <extra_id_0> Foxp3-GFP <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression ."]]}
{"trigger": ["All analyses and experiments were performed on animals at 6-8 wk of age .", "All analyses and experiments were performed on animals at 6-8 wk of age ."], "relation": []}
{"trigger": ["Animals were housed under specific pathogen-free conditions at the animal facility of the Skirball Institute , and experiments were performed in accordance with approved protocols for the New York University Institutional Animal Care and Usage Committee .", "Animals were housed under specific pathogen-free conditions at the animal facility of the Skirball Institute , and experiments were performed in accordance with approved protocols for the New York University Institutional Animal Care and Usage Committee ."], "relation": []}
{"trigger": ["Isolation of PBMCs , <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells , and culture conditions .", "Isolation of PBMCs , CD4 + T cells , and culture conditions ."], "relation": []}
{"trigger": ["Human PBMCs were isolated by Ficoll ( Biochrom ) density gradient centrifugation and <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were then isolated using the Dynal <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + Isolation <extra_id_0> kit <extra_id_2> Protein <extra_id_1> ( Invitrogen ) according to the manufacturer 's instructions .", "Human PBMCs were isolated by Ficoll ( Biochrom ) density gradient centrifugation and CD4 + T cells were then isolated using the Dynal CD4 + Isolation kit ( Invitrogen ) according to the manufacturer 's instructions ."], "relation": []}
{"trigger": ["The purity of <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells was initially tested by flow cytometry and was > / =95 % .", "The purity of CD4 + T cells was initially tested by flow cytometry and was > / =95 % ."], "relation": []}
{"trigger": ["Cells were stimulated with the following combination of mAbs to T cell surface molecules ( Meiler et al . , 2008 ) : anti - <extra_id_0> CD2 <extra_id_2> Protein <extra_id_1> ( clone 4B2 and 6G4 ; 0.5 microg / ml ) , anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> ( clone OKT3 ; 0.5 microg / ml ) , and anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> mAb ( clone B7G5 ; 0.5 microg / ml ; all from Sanquin ) and cultured in serum-free AIM - V medium ( Life Technologies ) with the addition of 1 nmol / liter <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> ( Roche ) .", "Cells were stimulated with the following combination of mAbs to T cell surface molecules ( Meiler et al . , 2008 ) : anti - CD2 ( clone 4B2 and 6G4 ; 0.5 microg / ml ) , anti - CD3 ( clone OKT3 ; 0.5 microg / ml ) , and anti - CD28 mAb ( clone B7G5 ; 0.5 microg / ml ; all from Sanquin ) and cultured in serum-free AIM - V medium ( Life Technologies ) with the addition of 1 nmol / liter IL-2 ( Roche ) ."], "relation": []}
{"trigger": ["<extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> ( R & D Systems ) was used at 5 ng / ml , if not stated otherwise .", "TGF-beta ( R & D Systems ) was used at 5 ng / ml , if not stated otherwise ."], "relation": []}
{"trigger": ["A combination of PMA ( 25 ng / ml ) and ionomycin ( 1 mg / ml ; Sigma-Aldrich ) was used .", "A combination of PMA ( 25 ng / ml ) and ionomycin ( 1 mg / ml ; Sigma-Aldrich ) was used ."], "relation": []}
{"trigger": ["Human <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD127 <extra_id_2> Protein <extra_id_1> - <extra_id_0> CD25 <extra_id_2> Protein <extra_id_1> high and <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD127 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD25 <extra_id_2> Protein <extra_id_1> neg cells were purified by flow cytometry using anti - <extra_id_0> CD127 <extra_id_2> Protein <extra_id_1> , anti - <extra_id_0> CD25 <extra_id_2> Protein <extra_id_1> - PC5 ( Beckman Coulter ) , and anti - <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> - FITC antibodies ( Dako ) .", "Human CD4 + CD127 - CD25 high and CD4 + CD127 + CD25 neg cells were purified by flow cytometry using anti - CD127 , anti - CD25 - PC5 ( Beckman Coulter ) , and anti - CD4 - FITC antibodies ( Dako ) ."], "relation": []}
{"trigger": ["Mouse naive ( <extra_id_0> CD62L <extra_id_2> Protein <extra_id_1> hi <extra_id_0> 44 <extra_id_2> Protein <extra_id_1> lo <extra_id_0> 25 <extra_id_2> Protein <extra_id_1> - ) <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were purified by flow cytometry and activated in vitro with 5 microg / ml plate - bound anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> and 1 microg / ml soluble anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> antibodies ( eBioscience ) in RPMI supplemented with 10 % FCS , 5 mM beta-mercaptoethanol , and antibiotics .", "Mouse naive ( CD62L hi 44 lo 25 - ) CD4 + T cells were purified by flow cytometry and activated in vitro with 5 microg / ml plate - bound anti - CD3 and 1 microg / ml soluble anti - CD28 antibodies ( eBioscience ) in RPMI supplemented with 10 % FCS , 5 mM beta-mercaptoethanol , and antibiotics ."], "relation": []}
{"trigger": ["Neutralizing anti - <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> and anti - <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> mAbs ( BD ) were used at 1 microg / ml concentrations when indicated .", "Neutralizing anti - IFN-gamma and anti - IL-4 mAbs ( BD ) were used at 1 microg / ml concentrations when indicated ."], "relation": []}
{"trigger": ["In vitro T cell differentiation .", "In vitro T cell differentiation ."], "relation": []}
{"trigger": ["<extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD45RA <extra_id_2> Protein <extra_id_1> + magnetically sorted ( <extra_id_0> CD45RO <extra_id_2> Protein <extra_id_1> depletion with AutoMACS ; Miltenyi Biotec ) cells were stimulated with immobilized plate - bound anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> ( 1 microg / ml ; OKT3 ; IgG1 ) and anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> ( 2 microg / ml ) .", "CD4 + CD45RA + magnetically sorted ( CD45RO <extra_id_0> depletion <extra_id_2> Negative_regulation <extra_id_1> with AutoMACS ; Miltenyi Biotec ) cells were stimulated with immobilized plate - bound anti - CD3 ( 1 microg / ml ; OKT3 ; IgG1 ) and anti - CD28 ( 2 microg / ml ) ."], "relation": [["CD4 + CD45RA + magnetically sorted ( CD45RO <extra_id_0> depletion <extra_id_2> Negative_regulation <extra_id_1> with AutoMACS ; Miltenyi Biotec ) cells were stimulated with immobilized plate - bound anti - CD3 ( 1 microg / ml ; OKT3 ; IgG1 ) and anti - CD28 ( 2 microg / ml ) .", "CD4 + CD45RA + magnetically sorted ( <extra_id_0> CD45RO <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> depletion with AutoMACS ; Miltenyi Biotec ) cells were stimulated with immobilized plate - bound anti - CD3 ( 1 microg / ml ; OKT3 ; IgG1 ) and anti - CD28 ( 2 microg / ml ) ."]]}
{"trigger": ["For Th1 differentiation conditions , cells were stimulated with the following : 40 ng / ml <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , 5 microg / ml anti - <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> , and 25 ng / ml <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> ( R & D Systems ) .", "For Th1 differentiation conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 5 microg / ml anti - IL-4 , and 25 ng / ml IL-12 ( R & D Systems ) ."], "relation": []}
{"trigger": ["For Th2 conditions , cells were stimulated with the following : 40 ng / ml <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , 25 ng / ml <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> , and 5 microg / ml anti - <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> ( R & D Systems ) .", "For Th2 conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 25 ng / ml IL-4 , and 5 microg / ml anti - IL-12 ( R & D Systems ) ."], "relation": []}
{"trigger": ["For T reg cell conditions , cells were stimulated with the following : 40 ng / ml <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , 5 ng / ml <extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> , 5 microg / ml anti - <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> , 5 microg / ml anti - <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> .", "For T reg cell conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 5 ng / ml TGF-beta , 5 microg / ml anti - IL-12 , 5 microg / ml anti - IL-4 ."], "relation": []}
{"trigger": ["For Th17 conditions , cells were stimulated with the following : 40 ng / ml <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , 20 ng / ml <extra_id_0> IL-6 <extra_id_2> Protein <extra_id_1> , 5 ng / ml <extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> , 20 ng / ml <extra_id_0> IL-23 <extra_id_2> Protein <extra_id_1> ( Alexis Biochemicals Corp . ) , 10 ng / ml <extra_id_0> IL-1beta <extra_id_2> Protein <extra_id_1> , 5 microg / ml anti - <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> , and 5 microg / ml anti - <extra_id_0> IL-12 <extra_id_2> Protein <extra_id_1> were used .", "For Th17 conditions , cells were stimulated with the following : 40 ng / ml IL-2 , 20 ng / ml IL-6 , 5 ng / ml TGF-beta , 20 ng / ml IL-23 ( Alexis Biochemicals Corp . ) , 10 ng / ml IL-1beta , 5 microg / ml anti - IL-4 , and 5 microg / ml anti - IL-12 were used ."], "relation": []}
{"trigger": ["Proliferating cells were expanded in medium containing <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> .", "Proliferating cells were expanded in medium containing IL-2 ."], "relation": []}
{"trigger": ["The cytokine profile of these cells demonstrated that <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> is the predominant cytokine in Th1 cells , <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> and <extra_id_0> IL-13 <extra_id_2> Protein <extra_id_1> in Th2 cells , and <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> in Th17 cells ( Akdis et al . , 2000 ; Burgler et al . , 2009 ) .", "The cytokine profile of these cells demonstrated that IFN-gamma is the predominant cytokine in Th1 cells , IL-4 and IL-13 in Th2 cells , and IL-17 in Th17 cells ( Akdis et al . , 2000 ; Burgler et al . , 2009 ) ."], "relation": []}
{"trigger": ["Immunohistochemistry .", "Immunohistochemistry ."], "relation": []}
{"trigger": ["Human tonsils were obtained from tonsillectomy samples of hypertrophic and obstructive tonsils without a current infection .", "Human tonsils were obtained from tonsillectomy samples of hypertrophic and obstructive tonsils without a current infection ."], "relation": []}
{"trigger": ["Ethical permission was obtained from Cantonal Ethics Commission , and informed consent was obtained from patients .", "Ethical permission was obtained from Cantonal Ethics Commission , and informed consent was obtained from patients ."], "relation": []}
{"trigger": ["Paraformaldehyde-fixed tonsil cryosections were stained with unconjugated rabbit IgG polyclonal antibody to human <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> ( Santa Cruz Biotechnology , Inc . ) or unconjugated mouse IgG1 mAb to human <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> ( Abcam ) .", "Paraformaldehyde-fixed tonsil cryosections were stained with unconjugated rabbit IgG polyclonal antibody to human RUNX1 ( Santa Cruz Biotechnology , Inc . ) or unconjugated mouse IgG1 mAb to human RUNX3 ( Abcam ) ."], "relation": []}
{"trigger": ["After a washing step , the sections were stained with the corresponding secondary antibodies .", "After a washing step , the sections were stained with the corresponding secondary antibodies ."], "relation": []}
{"trigger": ["<extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> - binding antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> - binding antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 .", "RUNX1 - <extra_id_0> binding <extra_id_2> Binding <extra_id_1> antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and RUNX3 - <extra_id_0> binding <extra_id_2> Binding <extra_id_1> antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 ."], "relation": [["RUNX1 - <extra_id_0> binding <extra_id_2> Binding <extra_id_1> antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and RUNX3 - binding antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 .", "<extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> - binding antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and RUNX3 - binding antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 ."], ["RUNX1 - binding antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and RUNX3 - <extra_id_0> binding <extra_id_2> Binding <extra_id_1> antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 .", "RUNX1 - binding antibodies were detected by using Alexa Fluor 633-conjugated goat anti-rabbit IgG and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> - binding antibodies were detected by using Alexa Fluor 532-conjugated goat anti-mouse IgG1 ."]]}
{"trigger": ["Afterward , the sections were washed and in the case of <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> staining a blocking step with an unconjugated mouse IgG1 mAb was used .", "Afterward , the sections were washed and in the case of RUNX3 staining a blocking step with an unconjugated mouse IgG1 mAb was used ."], "relation": []}
{"trigger": ["Finally , the sections were stained with Alexa Fluor 488-conjugated mouse IgG1 mAb to human <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> ( eBioscience ) or the corresponding isotype control .", "Finally , the sections were stained with Alexa Fluor 488-conjugated mouse IgG1 mAb to human FOXP3 ( eBioscience ) or the corresponding isotype control ."], "relation": []}
{"trigger": ["Tissue sections were stained with DAPI for the demonstration of nuclei and mounted with Prolong antifade ( Invitrogen ) .", "Tissue sections were stained with DAPI for the demonstration of nuclei and mounted with Prolong antifade ( Invitrogen ) ."], "relation": []}
{"trigger": ["Images were acquired and analyzed using the confocal microscope DMI 4000B and the TCS SPE system ( both from Leica ) .", "Images were acquired and analyzed using the confocal microscope DMI 4000B and the TCS SPE system ( both from Leica ) ."], "relation": []}
{"trigger": ["In vitro suppression assays .", "In vitro suppression assays ."], "relation": []}
{"trigger": ["Mouse <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + <extra_id_0> CD8 <extra_id_2> Protein <extra_id_1> - T cells were FACS purified based on <extra_id_0> GFP <extra_id_2> Protein <extra_id_1> expressed from a <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> - IRES - <extra_id_0> GFP <extra_id_2> Protein <extra_id_1> knock-in allele ( <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> <extra_id_0> GFP <extra_id_2> Protein <extra_id_1> ) .", "Mouse Foxp3 + CD4 + CD8 - T cells were FACS purified based on GFP <extra_id_0> expressed <extra_id_2> Gene_expression <extra_id_1> from a Foxp3 - IRES - GFP knock-in allele ( Foxp3 GFP ) ."], "relation": [["Mouse Foxp3 + CD4 + CD8 - T cells were FACS purified based on GFP <extra_id_0> expressed <extra_id_2> Gene_expression <extra_id_1> from a Foxp3 - IRES - GFP knock-in allele ( Foxp3 GFP ) .", "Mouse Foxp3 + CD4 + CD8 - T cells were FACS purified based on <extra_id_0> GFP <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expressed from a Foxp3 - IRES - GFP knock-in allele ( Foxp3 GFP ) ."]]}
{"trigger": ["Naive ( <extra_id_0> CD62L <extra_id_2> Protein <extra_id_1> hi <extra_id_0> 44 <extra_id_2> Protein <extra_id_1> lo <extra_id_0> 25 <extra_id_2> Protein <extra_id_1> - ) <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells ( effectors ) were FACS-purified from <extra_id_0> Cd45.1 <extra_id_2> Protein <extra_id_1> mice , then loaded with 5 microM CFSE ( Invitrogen ) .", "Naive ( CD62L hi 44 lo 25 - ) CD4 + T cells ( effectors ) were FACS-purified from Cd45.1 mice , then loaded with 5 microM CFSE ( Invitrogen ) ."], "relation": []}
{"trigger": ["Total splenocytes from C57BL / 6 mice inactivated with 50 microg / ml mitomycin C ( Sigma-Aldrich ) for 45 min were used as APCs .", "Total splenocytes from C57BL / 6 mice inactivated with 50 microg / ml mitomycin C ( Sigma-Aldrich ) for 45 min were used as APCs ."], "relation": []}
{"trigger": ["A total of 4 x 105 <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + cells ( CFSE-loaded <extra_id_0> CD25 <extra_id_2> Protein <extra_id_1> - plus <extra_id_0> Foxp3-GFP <extra_id_2> Protein <extra_id_1> + ) was mixed with 105 APCs + 1 microg / ml anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> mAb per well of a 96 well round bottom plate .", "A total of 4 x 105 CD4 + cells ( CFSE-loaded CD25 - plus Foxp3-GFP + ) was mixed with 105 APCs + 1 microg / ml anti - CD3 mAb per well of a 96 well round bottom plate ."], "relation": []}
{"trigger": ["Proliferation of the effector cells was analyzed by CFSE dilution .", "Proliferation of the effector cells was analyzed by CFSE dilution ."], "relation": []}
{"trigger": ["Apoptosis of the cells was investigated by <extra_id_0> annexin V <extra_id_2> Protein <extra_id_1> staining and flow cytometry .", "Apoptosis of the cells was investigated by annexin V staining and flow cytometry ."], "relation": []}
{"trigger": ["Positive and negative control gates were made according to T cells cultured only in the presence of <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> without anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 28 <extra_id_2> Protein <extra_id_1> stimulation .", "Positive and negative control gates were made according to T cells cultured only in the presence of IL-2 without anti - CD3 / 28 stimulation ."], "relation": []}
{"trigger": ["Human naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were isolated by negative selection by MACS from PBMCs and either transfected with a scrambled siRNA or with a combination of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> siRNA .", "Human naive CD4 + T cells were isolated by negative selection by MACS from PBMCs and either transfected with a scrambled siRNA or with a combination of RUNX1 and RUNX3 <extra_id_0> siRNA <extra_id_2> Negative_regulation <extra_id_1> ."], "relation": [["Human naive CD4 + T cells were isolated by negative selection by MACS from PBMCs and either transfected with a scrambled siRNA or with a combination of RUNX1 and RUNX3 <extra_id_0> siRNA <extra_id_2> Negative_regulation <extra_id_1> .", "Human naive CD4 + T cells were isolated by negative selection by MACS from PBMCs and either transfected with a scrambled siRNA or with a combination of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> siRNA ."]]}
{"trigger": ["Cells were then cultured under iT reg cell differentiating conditions and mixed with 2 x 105 autologous irradiated PBMCs that were used as APCs and autologous CFSE-labeled <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells .", "Cells were then cultured under iT reg cell differentiating conditions and mixed with 2 x 105 autologous irradiated PBMCs that were used as APCs and autologous CFSE-labeled CD4 + T cells ."], "relation": []}
{"trigger": ["T reg cell to responder cell ratio was 1 : 20 , 1 : 10 , and 1 : 5 .", "T reg cell to responder cell ratio was 1 : 20 , 1 : 10 , and 1 : 5 ."], "relation": []}
{"trigger": ["To check the proliferation of the <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells without suppression , no T reg cells were added in a control group .", "To check the proliferation of the CD4 + T cells without suppression , no T reg cells were added in a control group ."], "relation": []}
{"trigger": ["Cells were stimulated with 2.5 microg / ml anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> mAb , cultured in a 96-well plate and the proliferation of the effector cells was determined by analyzing the CFSE dilution by flow cytometry after 5 d of culture .", "Cells were stimulated with 2.5 microg / ml anti - CD3 mAb , cultured in a 96-well plate and the proliferation of the effector cells was determined by analyzing the CFSE dilution by flow cytometry after 5 d of culture ."], "relation": []}
{"trigger": ["Gating on the <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + CFSE+ T cells enabled the exclusion of APCs and T reg cells .", "Gating on the CD4 + CFSE+ T cells enabled the exclusion of APCs and T reg cells ."], "relation": []}
{"trigger": ["Cloning of the <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter , construction of mutant <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter , and <extra_id_0> RUNX <extra_id_2> Protein <extra_id_1> expression plasmids .", "Cloning of the FOXP3 promoter , construction of mutant FOXP3 promoter , and RUNX <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> plasmids ."], "relation": [["Cloning of the FOXP3 promoter , construction of mutant FOXP3 promoter , and RUNX <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> plasmids .", "Cloning of the FOXP3 promoter , construction of mutant FOXP3 promoter , and <extra_id_0> RUNX <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression plasmids ."]]}
{"trigger": ["The <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter was cloned into the pGL3 basic vector ( Promega Biotech ) to generate pGL3 <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> -511 / +176 ( Mantel et al . , 2006 ) .", "The FOXP3 promoter was cloned into the pGL3 basic vector ( Promega Biotech ) to generate pGL3 FOXP3 -511 / +176 ( Mantel et al . , 2006 ) ."], "relation": []}
{"trigger": ["Site - directed mutagenesis for the three putative RUNX binding sites in the <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter region was introduced using the QuickChange kit ( Stratagene ) , according to the manufacturer 's instructions and confirmed by sequencing the DNA .", "Site - directed mutagenesis for the three putative RUNX binding sites in the FOXP3 promoter region was introduced using the QuickChange kit ( Stratagene ) , according to the manufacturer 's instructions and confirmed by sequencing the DNA ."], "relation": []}
{"trigger": ["The following primers and their complementary strands were used : foxp runx-333 , forward 5'-CACTTTTGTTTTAAAAACTGTCCTTTCTCATGAGCCCTATTATC-3 ' ; foxp runx-333 reverse 5'-GATAATAGGGCTCATGAGAAAGGACAGTTTTTAAAACAAAAGTG-3 ' ; foxp runx-287 forward 5'-CCTCTCACCTCTGTCCTGAGGGGAAGAAATC-3 ' ; foxp runx-287 reverse 5'-GATTTCTTCCCCTCAGGACAGAGGTGAGAGG-3 ' ; foxp runx-53 forward 5'-GCTTCCACACCGTACAGCGTCCTTTTTCTTCTCGGTATAAAAG-3 ' ; foxp runx-53 reverse 5'-CTTTTATACCGAGAAGAAAAAGGACGCTGTACGGTGTGGAAGC-3 ' .", "The following primers and their complementary strands were used : foxp runx-333 , forward 5'-CACTTTTGTTTTAAAAACTGTCCTTTCTCATGAGCCCTATTATC-3 ' ; foxp runx-333 reverse 5'-GATAATAGGGCTCATGAGAAAGGACAGTTTTTAAAACAAAAGTG-3 ' ; foxp runx-287 forward 5'-CCTCTCACCTCTGTCCTGAGGGGAAGAAATC-3 ' ; foxp runx-287 reverse 5'-GATTTCTTCCCCTCAGGACAGAGGTGAGAGG-3 ' ; foxp runx-53 forward 5'-GCTTCCACACCGTACAGCGTCCTTTTTCTTCTCGGTATAAAAG-3 ' ; foxp runx-53 reverse 5'-CTTTTATACCGAGAAGAAAAAGGACGCTGTACGGTGTGGAAGC-3 ' ."], "relation": []}
{"trigger": ["The human <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> fragment from the Addgene plasmid 12504 ( Biggs et al . , 2006 ) pFlagCMV2-AML1B was sub-cloned in the pEGFPN1 vector ( Clontech Laboratories ) .", "The human RUNX1 fragment from the Addgene plasmid 12504 ( Biggs et al . , 2006 ) pFlagCMV2-AML1B was sub-cloned in the pEGFPN1 vector ( Clontech Laboratories ) ."], "relation": []}
{"trigger": ["The <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> vector pCMV human <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> , which was a gift from K . Ito ( Institute of Molecular and Cell Biology , Proteos , Singapore ) was subcloned into pEGFPN1 vector ( Clontech Laboratories ; Yamamura et al . , 2006 ) .", "The RUNX3 vector pCMV human RUNX3 , which was a gift from K . Ito ( Institute of Molecular and Cell Biology , Proteos , Singapore ) was subcloned into pEGFPN1 vector ( Clontech Laboratories ; Yamamura et al . , 2006 ) ."], "relation": []}
{"trigger": ["Transfections and reporter gene assays .", "Transfections and reporter gene assays ."], "relation": []}
{"trigger": ["T cells were rested in serum-free AIM-V medium overnight .", "T cells were rested in serum-free AIM-V medium overnight ."], "relation": []}
{"trigger": ["3.5 microg of the <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter <extra_id_0> luciferase <extra_id_2> Protein <extra_id_1> reporter vector or a combination together with the <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> , <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> pEGFPN1 vector , and 0.5 microg phRL-TK were added to 3 x 106 <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated using the program U-15 .", "3.5 microg of the FOXP3 promoter luciferase reporter vector or a combination together with the RUNX1 , RUNX3 pEGFPN1 vector , and 0.5 microg phRL-TK were added to 3 x 106 CD4 + T cells resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated using the program U-15 ."], "relation": []}
{"trigger": ["After a 24-h culture in serum-free conditions and stimuli as indicated in the figures , <extra_id_0> luciferase <extra_id_2> Protein <extra_id_1> activity was measured by the dual <extra_id_0> luciferase <extra_id_2> Protein <extra_id_1> assay system ( Promega ) according to the manufacturer 's instructions .", "After a 24-h culture in serum-free conditions and stimuli as indicated in the figures , luciferase activity was measured by the dual luciferase assay system ( Promega ) according to the manufacturer 's instructions ."], "relation": []}
{"trigger": ["PMA / ionomycin was used to stimulate the cells , because the transfection was only transient and the <extra_id_0> luciferase <extra_id_2> Protein <extra_id_1> assay required a strong and fast stimulation of the cells .", "PMA / ionomycin was used to stimulate the cells , because the transfection was only transient and the luciferase assay required a strong and fast stimulation of the cells ."], "relation": []}
{"trigger": ["To evaluate the effect of overexpression of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> on <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> protein levels , <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were preactivated with 2 microg / ml <extra_id_0> phytohemagglutinin <extra_id_2> Protein <extra_id_1> ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 .", "To evaluate the <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> of <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_1> of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 ."], "relation": [["To evaluate the <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> of overexpression of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 .", "To evaluate the effect of <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_2> Cause <extra_id_1> overexpression <extra_id_2> Gene_expression <extra_id_2> Cause <extra_id_1> of RUNX1 or RUNX3 on <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 ."], ["To evaluate the effect of <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_1> of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 .", "To evaluate the effect of overexpression of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 ."], ["To evaluate the effect of overexpression of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 .", "To evaluate the effect of overexpression of RUNX1 or RUNX3 on FOXP3 protein levels , CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma-Aldrich ) in serum-free AIM-V medium in the presence of 1 nmol / liter IL-2 ( Roche ) for 12 h , and then transfected with the vector pEGFPN1 containing the <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> fragment using the Nucleofector system ( Amaxa Biosystems ) and the program T-23 ."]]}
{"trigger": ["<extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> expression was evaluated by flow cytometry after 48 h of culture in AIM-V medium containing 1 nmol / liter <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> .", "FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> was evaluated by flow cytometry after 48 h of culture in AIM-V medium containing 1 nmol / liter IL-2 ."], "relation": [["FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> was evaluated by flow cytometry after 48 h of culture in AIM-V medium containing 1 nmol / liter IL-2 .", "<extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression was evaluated by flow cytometry after 48 h of culture in AIM-V medium containing 1 nmol / liter IL-2 ."]]}
{"trigger": ["RNA interference .", "RNA interference ."], "relation": []}
{"trigger": ["<extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + or naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated with 2 microM siRNA using the Nucleofector technology program U-14 ( Lonza ) .", "CD4 + or naive CD4 + T cells were resuspended in 100 microl of Nucleofector solution ( Lonza ) and electroporated with 2 microM siRNA using the Nucleofector technology program U-14 ( Lonza ) ."], "relation": []}
{"trigger": ["Five different Silencer or Silencer Select Pre-designed siRNAs for <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> ( Applied Biosystems ) and three Silencer Pre-designed siRNAs for <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> ( Applied Biosystems ) were tested , and the best was selected for all further experiments .", "Five different Silencer or Silencer Select Pre-designed <extra_id_0> siRNAs <extra_id_2> Negative_regulation <extra_id_1> for RUNX1 ( Applied Biosystems ) and three Silencer Pre-designed <extra_id_0> siRNAs <extra_id_2> Negative_regulation <extra_id_1> for RUNX3 ( Applied Biosystems ) were tested , and the best was selected for all further experiments ."], "relation": [["Five different Silencer or Silencer Select Pre-designed <extra_id_0> siRNAs <extra_id_2> Negative_regulation <extra_id_1> for RUNX1 ( Applied Biosystems ) and three Silencer Pre-designed siRNAs for RUNX3 ( Applied Biosystems ) were tested , and the best was selected for all further experiments .", "Five different Silencer or Silencer Select Pre-designed siRNAs for <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( Applied Biosystems ) and three Silencer Pre-designed siRNAs for RUNX3 ( Applied Biosystems ) were tested , and the best was selected for all further experiments ."], ["Five different Silencer or Silencer Select Pre-designed siRNAs for RUNX1 ( Applied Biosystems ) and three Silencer Pre-designed <extra_id_0> siRNAs <extra_id_2> Negative_regulation <extra_id_1> for RUNX3 ( Applied Biosystems ) were tested , and the best was selected for all further experiments .", "Five different Silencer or Silencer Select Pre-designed siRNAs for RUNX1 ( Applied Biosystems ) and three Silencer Pre-designed siRNAs for <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( Applied Biosystems ) were tested , and the best was selected for all further experiments ."]]}
{"trigger": ["The Silencer Negative Control # 1 siRNA ( Applied Biosystems ) was used for normalization .", "The Silencer Negative Control # 1 siRNA ( Applied Biosystems ) was used for normalization ."], "relation": []}
{"trigger": ["Cells were then left unstimulated or were stimulated after 12 h with anti - <extra_id_0> CD2 <extra_id_2> Protein <extra_id_1> , anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> , and anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> .", "Cells were then left unstimulated or were stimulated after 12 h with anti - CD2 , anti - CD3 , and anti - CD28 ."], "relation": []}
{"trigger": ["Cells were cultured in serum-free <extra_id_0> AIM-V <extra_id_2> Protein <extra_id_1> medium with the addition of 1 nmol / l <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> ( Roche ) .", "Cells were cultured in serum-free AIM-V medium with the addition of 1 nmol / l IL-2 ( Roche ) ."], "relation": []}
{"trigger": ["Cells were harvested for mRNA detection of the target genes after 24 h and for protein detection after 48 h .", "Cells were harvested for mRNA detection of the target genes after 24 h and for protein detection after 48 h ."], "relation": []}
{"trigger": ["RNA isolation and cDNA synthesis .", "RNA isolation and cDNA synthesis ."], "relation": []}
{"trigger": ["RNA was isolated using the RNeasy Mini kit ( QIAGEN ) according to the manufacturer 's protocol .", "RNA was isolated using the RNeasy Mini kit ( QIAGEN ) according to the manufacturer 's protocol ."], "relation": []}
{"trigger": ["Reverse transcription of human samples was performed with reverse - transcription reagents ( Fermentas ) with random hexamers according to the manufacturer 's protocol .", "Reverse transcription of human samples was performed with reverse - transcription reagents ( Fermentas ) with random hexamers according to the manufacturer 's protocol ."], "relation": []}
{"trigger": ["Real-time PCR .", "Real-time PCR ."], "relation": []}
{"trigger": ["PCR primers and probes were designed based on the sequences reported in GenBank with the Primer Express software version 1.2 ( Applied Biosystems ) as follows : <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> forward primer , 5'-GAAACAGCACATTCCCAGAGTTC-3 ' ; <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> reverse primer , 5'-ATGGCCCAGCGGATGAG-3 ' ; <extra_id_0> EF-1a <extra_id_2> Protein <extra_id_1> forward primer , 5'-CTGAACCATCCAGGCCAAAT-3 ' ; and <extra_id_0> EF-1a <extra_id_2> Protein <extra_id_1> reverse primer , 5'-GCCGTGTGGCAATCCAAT-3 ' , as previously described ( Mantel et al . , 2007 ) .", "PCR primers and probes were designed based on the sequences reported in GenBank with the Primer Express software version 1.2 ( Applied Biosystems ) as follows : FOXP3 forward primer , 5'-GAAACAGCACATTCCCAGAGTTC-3 ' ; FOXP3 reverse primer , 5'-ATGGCCCAGCGGATGAG-3 ' ; EF-1a forward primer , 5'-CTGAACCATCCAGGCCAAAT-3 ' ; and EF-1a reverse primer , 5'-GCCGTGTGGCAATCCAAT-3 ' , as previously described ( Mantel et al . , 2007 ) ."], "relation": []}
{"trigger": ["<extra_id_0> GATA3 <extra_id_2> Protein <extra_id_1> forward primer , 5'-GCGGGCTCTATCACAAAATGA-3 ' ; and <extra_id_0> GATA3 <extra_id_2> Protein <extra_id_1> reverse primer 5'-GCTCTCCTGGCTGCAGACAGC-3 ' ( Mantel et al . , 2007 ) .", "GATA3 forward primer , 5'-GCGGGCTCTATCACAAAATGA-3 ' ; and GATA3 reverse primer 5'-GCTCTCCTGGCTGCAGACAGC-3 ' ( Mantel et al . , 2007 ) ."], "relation": []}
{"trigger": ["<extra_id_0> T-bet <extra_id_2> Protein <extra_id_1> forward primer , 5'-GATGCGCCAGGAAGTTTCAT-3 ' ; <extra_id_0> T-bet <extra_id_2> Protein <extra_id_1> reverse primer , 5'-GCACAATCATCTGGGTCACATT-3 ' ; <extra_id_0> RORC2 <extra_id_2> Protein <extra_id_1> forward primer , 5'-CAGTCATGAGAACACAAATTGAAGTG-3 ' ; and <extra_id_0> RORC2 <extra_id_2> Protein <extra_id_1> reverse primer 5'-CAGGTGATAACCCCGTAGTGGAT-3 ' .", "T-bet forward primer , 5'-GATGCGCCAGGAAGTTTCAT-3 ' ; T-bet reverse primer , 5'-GCACAATCATCTGGGTCACATT-3 ' ; RORC2 forward primer , 5'-CAGTCATGAGAACACAAATTGAAGTG-3 ' ; and RORC2 reverse primer 5'-CAGGTGATAACCCCGTAGTGGAT-3 ' ."], "relation": []}
{"trigger": ["The prepared cDNAs were amplified using SYBR green PCR master mix ( Fermentas ) according to the recommendations of the manufacturer in an ABI PRISM 7000 Sequence Detection System ( Applied Biosystems ) .", "The prepared cDNAs were amplified using SYBR green PCR master mix ( Fermentas ) according to the recommendations of the manufacturer in an ABI PRISM 7000 Sequence Detection System ( Applied Biosystems ) ."], "relation": []}
{"trigger": ["<extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> mRNA was detected by using TaqMan Gene Expression Assays from Applied Biosystems and used according to the manufacturer 's instruction using TaqMan master mix using a 7000 real-time PCR system ( Applied Biosystems ) .", "RUNX1 and RUNX3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> was detected by using TaqMan Gene Expression Assays from Applied Biosystems and used according to the manufacturer 's instruction using TaqMan master mix using a 7000 real-time PCR system ( Applied Biosystems ) ."], "relation": [["RUNX1 and RUNX3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> was detected by using TaqMan Gene Expression Assays from Applied Biosystems and used according to the manufacturer 's instruction using TaqMan master mix using a 7000 real-time PCR system ( Applied Biosystems ) .", "<extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> mRNA was detected by using TaqMan Gene Expression Assays from Applied Biosystems and used according to the manufacturer 's instruction using TaqMan master mix using a 7000 real-time PCR system ( Applied Biosystems ) ."]]}
{"trigger": ["PCR amplification of the housekeeping gene encoding <extra_id_0> elongation factor (EF)-1alpha <extra_id_2> Protein <extra_id_1> or by using the <extra_id_0> 18S rRNA <extra_id_2> Protein <extra_id_1> Gene Expression Assay ( Applied Biosystems ) was performed to allow normalization between samples .", "PCR amplification of the housekeeping gene encoding elongation factor (EF)-1alpha or by using the 18S rRNA Gene Expression Assay ( Applied Biosystems ) was performed to allow normalization between samples ."], "relation": []}
{"trigger": ["Relative quantification and calculation of the range of confidence was performed using the comparative DeltaDeltaCT method ( Applied Biosystems ) .", "Relative quantification and calculation of the range of confidence was performed using the comparative DeltaDeltaCT method ( Applied Biosystems ) ."], "relation": []}
{"trigger": ["The percentage of <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> mRNA in siRNA - mediated <extra_id_0> RUNX <extra_id_2> Protein <extra_id_1> knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA .", "The percentage of FOXP3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> in siRNA - <extra_id_0> mediated <extra_id_2> Positive_regulation <extra_id_1> RUNX <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> cells was calculated in relation to cells , which were transfected with scrambled control siRNA ."], "relation": [["The percentage of FOXP3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> in siRNA - mediated RUNX knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA .", "The percentage of <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> mRNA in siRNA - mediated RUNX knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA ."], ["The percentage of FOXP3 mRNA in siRNA - <extra_id_0> mediated <extra_id_2> Positive_regulation <extra_id_1> RUNX knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA .", "The percentage of FOXP3 mRNA in siRNA - mediated RUNX <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_2> Theme <extra_id_1> cells was calculated in relation to cells , which were transfected with scrambled control siRNA ."], ["The percentage of FOXP3 mRNA in siRNA - mediated RUNX <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> cells was calculated in relation to cells , which were transfected with scrambled control siRNA .", "The percentage of FOXP3 mRNA in siRNA - mediated <extra_id_0> RUNX <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> knockdown cells was calculated in relation to cells , which were transfected with scrambled control siRNA ."]]}
{"trigger": ["Arbitrary units show the 2 - ( Deltact ) values multiplied by 10 , 000 incorporating the ct values of the gene of interest and the housekeeping gene .", "Arbitrary units show the 2 - ( Deltact ) values multiplied by 10 , 000 incorporating the ct values of the gene of interest and the housekeeping gene ."], "relation": []}
{"trigger": ["Flow cytometry .", "Flow cytometry ."], "relation": []}
{"trigger": ["For analysis of human <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> expression on the single-cell level , cells were first stained with the monoclonal <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> mAb ( Beckman Coulter ) , and after fixation and permeabilization , they were incubated with anti-human <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> - Alexa Fluor 488 antibody ( BioLegend ) based on the manufacturer 's recommendations and subjected to FACS ( EPICS XL-MCL ; Beckman Coulter ) .", "For analysis of human FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> on the single-cell level , cells were first stained with the monoclonal CD4 mAb ( Beckman Coulter ) , and after fixation and permeabilization , they were incubated with anti-human Foxp3 - Alexa Fluor 488 antibody ( BioLegend ) based on the manufacturer 's recommendations and subjected to FACS ( EPICS XL-MCL ; Beckman Coulter ) ."], "relation": [["For analysis of human FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> on the single-cell level , cells were first stained with the monoclonal CD4 mAb ( Beckman Coulter ) , and after fixation and permeabilization , they were incubated with anti-human Foxp3 - Alexa Fluor 488 antibody ( BioLegend ) based on the manufacturer 's recommendations and subjected to FACS ( EPICS XL-MCL ; Beckman Coulter ) .", "For analysis of human <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression on the single-cell level , cells were first stained with the monoclonal CD4 mAb ( Beckman Coulter ) , and after fixation and permeabilization , they were incubated with anti-human Foxp3 - Alexa Fluor 488 antibody ( BioLegend ) based on the manufacturer 's recommendations and subjected to FACS ( EPICS XL-MCL ; Beckman Coulter ) ."]]}
{"trigger": ["A mouse IgG1 antibody ( BioLegend ) was used as an isotype control .", "A mouse IgG1 antibody ( BioLegend ) was used as an isotype control ."], "relation": []}
{"trigger": ["Data were analyzed with the CXP software ( Beckman Coulter ) .", "Data were analyzed with the CXP software ( Beckman Coulter ) ."], "relation": []}
{"trigger": ["Cells were cultured with <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , and then left unstimulated or stimulated with anti - <extra_id_0> CD2 <extra_id_2> Protein <extra_id_1> / - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> / - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> mAb .", "Cells were cultured with IL-2 , and then left unstimulated or stimulated with anti - CD2 / - CD3 / - CD28 mAb ."], "relation": []}
{"trigger": ["Flow cytometry analyses of the mouse cells were performed on an LSRII ( BD ) and cell sorting was performed on a FACSAria ( BD ) .", "Flow cytometry analyses of the mouse cells were performed on an LSRII ( BD ) and cell sorting was performed on a FACSAria ( BD ) ."], "relation": []}
{"trigger": ["All antibodies for these experiments were purchased from eBioscience or BD .", "All antibodies for these experiments were purchased from eBioscience or BD ."], "relation": []}
{"trigger": ["Western blotting .", "Western blotting ."], "relation": []}
{"trigger": ["For human <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> analysis on the protein level , 106 cells were lysed and loaded next to a protein - mass ladder ( Invitrogen ) on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen ) .", "For human RUNX1 and RUNX3 analysis on the <extra_id_0> protein level <extra_id_2> Gene_expression <extra_id_1> , 106 cells were lysed and loaded next to a protein - mass ladder ( Invitrogen ) on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen ) ."], "relation": [["For human RUNX1 and RUNX3 analysis on the <extra_id_0> protein level <extra_id_2> Gene_expression <extra_id_1> , 106 cells were lysed and loaded next to a protein - mass ladder ( Invitrogen ) on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen ) .", "For human <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> analysis on the protein level , 106 cells were lysed and loaded next to a protein - mass ladder ( Invitrogen ) on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen ) ."]]}
{"trigger": ["The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) .", "The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) ."], "relation": []}
{"trigger": ["Unspecific binding was blocked with 3 % milk in TBS Tween , and the membranes were subsequently incubated with a 1 : 1 , 000 dilution of rabbit anti - <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> ( ab11903 ; Abcam ) or 1 : 200 dilution of rabbit anti - <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> ( H-50 ; Santa Cruz Biotechnology , Inc . ) in blocking buffer containing 3 % milk in TBS Tween overnight at 4degreesC .", "Unspecific binding was blocked with 3 % milk in TBS Tween , and the membranes were subsequently incubated with a 1 : 1 , 000 dilution of rabbit anti - RUNX1 ( ab11903 ; Abcam ) or 1 : 200 dilution of rabbit anti - RUNX3 ( H-50 ; Santa Cruz Biotechnology , Inc . ) in blocking buffer containing 3 % milk in TBS Tween overnight at 4degreesC ."], "relation": []}
{"trigger": ["The blots were developed using an anti-rabbit IgG HRP-labeled mAb ( Cell Signaling Technology ) and visualized with a LAS-1000 gel documentation system ( Fujifilm ) .", "The blots were developed using an anti-rabbit IgG HRP-labeled mAb ( Cell Signaling Technology ) and visualized with a LAS-1000 gel documentation system ( Fujifilm ) ."], "relation": []}
{"trigger": ["To confirm sample loading and transfer membranes were incubated in stripping buffer and reblocked for 1 h and reprobed using anti - <extra_id_0> GAPDH <extra_id_2> Protein <extra_id_1> ( 6C5 ; Ambion ) and developed using an anti-mouse IgG HRP-labeled mAb ( Cell Signaling Technology ) .", "To confirm sample loading and transfer membranes were incubated in stripping buffer and reblocked for 1 h and reprobed using anti - GAPDH ( 6C5 ; Ambion ) and developed using an anti-mouse IgG HRP-labeled mAb ( Cell Signaling Technology ) ."], "relation": []}
{"trigger": ["Pull-down assay .", "Pull-down assay ."], "relation": []}
{"trigger": ["HEK293T cells were transfected with <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction .", "HEK293T cells were <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with RUNX1 or RUNX3 using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction ."], "relation": [["HEK293T cells were <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with RUNX1 or RUNX3 using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction .", "HEK293T cells were transfected with <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> using the Lipofectamine 2000 reagent ( Invitrogen ) according to the manufacturer 's instruction ."]]}
{"trigger": ["Cells were lysed by sonication in HKMG buffer ( 10 mM Hepes , pH 7.9 , 100 mM KCl , 5 mM MgCl2 , 10 % glycerol , 1 mM DTT , 0.5 % Nonidet P-40 ) containing a protease inhibitor cocktail ( Roche Diagnostics ) .", "Cells were lysed by sonication in HKMG buffer ( 10 mM Hepes , pH 7.9 , 100 mM KCl , 5 mM MgCl2 , 10 % glycerol , 1 mM DTT , 0.5 % Nonidet P-40 ) containing a protease inhibitor cocktail ( Roche Diagnostics ) ."], "relation": []}
{"trigger": ["The cell lysate was precleared using streptavidin-agarose beads ( GE Healthcare ) , incubated with biotinylated double-stranded oligonucleotides containing the wild-type or mutated RUNX binding sites , and polydeoxyinosinicdeoxycytidylic acid ( Sigma-Aldrich ) .", "The cell lysate was precleared using streptavidin-agarose beads ( GE Healthcare ) , incubated with biotinylated double-stranded oligonucleotides containing the wild-type or mutated RUNX binding sites , and polydeoxyinosinicdeoxycytidylic acid ( Sigma-Aldrich ) ."], "relation": []}
{"trigger": ["A combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used in the assay .", "A combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used in the assay ."], "relation": []}
{"trigger": ["DNA - bound proteins were collected with streptavidin-agarose beads , washed with HKMG buffer , and finally resuspended in NuPAGE loading buffer ( Invitrogen Life Technologies ) , heated to 70degreesC for 10 min , and separated on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen Life Technologies ) .", "DNA - bound proteins were collected with streptavidin-agarose beads , washed with HKMG buffer , and finally resuspended in NuPAGE loading buffer ( Invitrogen Life Technologies ) , heated to 70degreesC for 10 min , and separated on a NuPAGE 4-12 % Bis-Tris gel ( Invitrogen Life Technologies ) ."], "relation": []}
{"trigger": ["The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) and detected using <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> antibodies described in the previous section .", "The proteins were electroblotted onto a PVDF membrane ( GE Healthcare ) and detected using RUNX1 or RUNX3 antibodies described in the previous section ."], "relation": []}
{"trigger": ["Promoter enzyme immuno assay .", "Promoter enzyme immuno assay ."], "relation": []}
{"trigger": ["As performed in the pull-down assay , <extra_id_0> HEK293T cells <extra_id_2> Protein <extra_id_1> were transfected with <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> and subsequently lysed .", "As performed in the pull-down assay , HEK293T cells were <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with RUNX1 or RUNX3 and subsequently lysed ."], "relation": [["As performed in the pull-down assay , HEK293T cells were <extra_id_0> transfected <extra_id_2> Gene_expression <extra_id_1> with RUNX1 or RUNX3 and subsequently lysed .", "As performed in the pull-down assay , HEK293T cells were transfected with <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and subsequently lysed ."]]}
{"trigger": ["Insoluble material was removed by centrifugation .", "Insoluble material was removed by centrifugation ."], "relation": []}
{"trigger": ["384-well plates , precoated with streptavidin ( Thermo Fisher Scientific ) were washed 3 times with washing buffer ( PBS and 0.05 % Tween 20 ) .", "384-well plates , precoated with streptavidin ( Thermo Fisher Scientific ) were washed 3 times with washing buffer ( PBS and 0.05 % Tween 20 ) ."], "relation": []}
{"trigger": ["Biotinylated <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter / oligonucleotides probes containing the RUNX binding sites were added ( 1 pmol per well ; 50 fmol / microl ) and incubated for 1 h at room temperature .", "Biotinylated FOXP3 promoter / oligonucleotides probes containing the RUNX binding sites were added ( 1 pmol per well ; 50 fmol / microl ) and incubated for 1 h at room temperature ."], "relation": []}
{"trigger": ["Either a combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used or single oligonucleotides were used in the assay .", "Either a combination of all three oligonucleotides containing the mutated or the wild-type binding sites was used or single oligonucleotides were used in the assay ."], "relation": []}
{"trigger": ["After 3 washing steps with washing buffer , the nuclear extract was added ( concentration > 0.2 microg / microl ) and incubated overnight at 4degreesC .", "After 3 washing steps with washing buffer , the nuclear extract was added ( concentration > 0.2 microg / microl ) and incubated overnight at 4degreesC ."], "relation": []}
{"trigger": ["The lysates were incubated with 10 microg of poly-deoxyinosinic-deoxycytidylic acid ( Sigma-Aldrich ) .", "The lysates were incubated with 10 microg of poly-deoxyinosinic-deoxycytidylic acid ( Sigma-Aldrich ) ."], "relation": []}
{"trigger": ["The plate was washed with HKMG buffer and incubated with a 1 : 1000 dilution of rabbit anti - <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> ( ab11903 , Abcam ) or 1 : 200 dilution of rabbit anti - <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> ( H-50 , Santa Cruz Biotechnology , Inc . ) at 4degreesC for 2 h .", "The plate was washed with HKMG buffer and incubated with a 1 : 1000 dilution of rabbit anti - RUNX1 ( ab11903 , Abcam ) or 1 : 200 dilution of rabbit anti - RUNX3 ( H-50 , Santa Cruz Biotechnology , Inc . ) at 4degreesC for 2 h ."], "relation": []}
{"trigger": ["After three washing steps with HKMG buffer , a secondary antibody ( anti-rabbit IgG-HRP , 1 : 3 , 000 in HKMG buffer , Cell Signaling Technology ) was added , and the plate was incubated for 1 h at 4degreesC .", "After three washing steps with HKMG buffer , a secondary antibody ( anti-rabbit IgG-HRP , 1 : 3 , 000 in HKMG buffer , Cell Signaling Technology ) was added , and the plate was incubated for 1 h at 4degreesC ."], "relation": []}
{"trigger": ["The wells were washed 4 times with HKMG buffer before adding the substrate reagent ( R & D Systems ) .", "The wells were washed 4 times with HKMG buffer before adding the substrate reagent ( R & D Systems ) ."], "relation": []}
{"trigger": ["The colorimetric reaction was stopped by adding 2 M H2SO4 .", "The colorimetric reaction was stopped by adding 2 M H2SO4 ."], "relation": []}
{"trigger": ["Absorbance at 450 nm was measured using a microplate reader ( Berthold Technologies ) .", "Absorbance at 450 nm was measured using a microplate reader ( Berthold Technologies ) ."], "relation": []}
{"trigger": ["ChIP .", "ChIP ."], "relation": []}
{"trigger": ["Human naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells were cultured either with <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> only or with <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> , anti - <extra_id_0> CD2 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 3 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 28 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> for 72 h , and protein - DNA complexes were fixed by cross-linking with formaldehyde in a final concentration of 1.42 % for 15 min .", "Human naive CD4 + T cells were cultured either with IL-2 only or with IL-2 , anti - CD2 / 3 / 28 , and TGF-beta for 72 h , and protein - DNA complexes were fixed by cross-linking with formaldehyde in a final concentration of 1.42 % for 15 min ."], "relation": []}
{"trigger": ["Formaldehyde was quenched with 125 mM glycine for 5 min , and cells were subsequently harvested .", "Formaldehyde was quenched with 125 mM glycine for 5 min , and cells were subsequently harvested ."], "relation": []}
{"trigger": ["The ChIP assay was performed as described in the fast chromatin immunoprecipitation method ( Nelson et al . , 2006 ) .", "The ChIP assay was performed as described in the fast chromatin immunoprecipitation method ( Nelson et al . , 2006 ) ."], "relation": []}
{"trigger": ["Cells were lysed with immunoprecipitation buffer ( 150 mM NaCl , 50 mM Tris-HCl , pH 7.5 , 5 mM EDTA , NP-40 [ 0.5 % vol / vol ] ) containing phosphatase ( Roche ) and protease inhibitors cocktails ( Roche ) , the nuclear pellet was washed , the chromatin was sheared by sonication and incubated with antibodies for <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> ( H-65 X ; Santa Cruz Biotechnology , Inc . ) , <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> ( H-50 X ; Santa Cruz Biotechnology , Inc . ) , <extra_id_0> CBFbeta <extra_id_2> Protein <extra_id_1> ( PEBP2beta ; FL-182 X ; Santa Cruz Biotechnology , Inc . ) , and as controls normal rabbit IgG ( Santa Cruz Biotechnology , Inc . ) , anti-human <extra_id_0> RNA polymerase II <extra_id_2> Protein <extra_id_1> antibody , and mouse control IgG ( both from SA Biosciences ) .", "Cells were lysed with immunoprecipitation buffer ( 150 mM NaCl , 50 mM Tris-HCl , pH 7.5 , 5 mM EDTA , NP-40 [ 0.5 % vol / vol ] ) containing phosphatase ( Roche ) and protease inhibitors cocktails ( Roche ) , the nuclear pellet was washed , the chromatin was sheared by sonication and incubated with antibodies for RUNX1 ( H-65 X ; Santa Cruz Biotechnology , Inc . ) , RUNX3 ( H-50 X ; Santa Cruz Biotechnology , Inc . ) , CBFbeta ( PEBP2beta ; FL-182 X ; Santa Cruz Biotechnology , Inc . ) , and as controls normal rabbit IgG ( Santa Cruz Biotechnology , Inc . ) , anti-human RNA polymerase II antibody , and mouse control IgG ( both from SA Biosciences ) ."], "relation": []}
{"trigger": ["The cleared chromatin was incubated with <extra_id_0> protein A <extra_id_2> Protein <extra_id_1> agarose beads and , after several washing steps , DNA was isolated with 10 % ( wt / vol ) Chelex 100 resin .", "The cleared chromatin was incubated with protein A agarose beads and , after several washing steps , DNA was isolated with 10 % ( wt / vol ) Chelex 100 resin ."], "relation": []}
{"trigger": ["Samples were treated with <extra_id_0> proteinase K <extra_id_2> Protein <extra_id_1> at 55degreesC for 30 min .", "Samples were treated with proteinase K at 55degreesC for 30 min ."], "relation": []}
{"trigger": ["The <extra_id_0> proteinase K <extra_id_2> Protein <extra_id_1> was then inactivated by boiling the samples for 10 min .", "The proteinase K was then inactivated by boiling the samples for 10 min ."], "relation": []}
{"trigger": ["The purified DNA was used in a real-time PCR reaction .", "The purified DNA was used in a real-time PCR reaction ."], "relation": []}
{"trigger": ["Specific primers for the <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter , spanning the region from -87 to -3 , <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter forward primer 5'-AGAGGTCTGCGGCTTCCA-3 ' , <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> promoter reverse primer 5'-GGAAACTGTCACGTATCAAAAACAA-3 ' , or control <extra_id_0> GAPDH <extra_id_2> Protein <extra_id_1> primer ( SA Biosciences ) for the <extra_id_0> RNA polymerase II <extra_id_2> Protein <extra_id_1> were used .", "Specific primers for the FOXP3 promoter , spanning the region from -87 to -3 , FOXP3 promoter forward primer 5'-AGAGGTCTGCGGCTTCCA-3 ' , FOXP3 promoter reverse primer 5'-GGAAACTGTCACGTATCAAAAACAA-3 ' , or control GAPDH primer ( SA Biosciences ) for the RNA polymerase II were used ."], "relation": []}
{"trigger": ["A negative control PCR for each immunoprecipitation using IGX1A negative control primer targeting ORF-free intergenic DNA ( SA Biosciences ) was used .", "A negative control PCR for each immunoprecipitation using IGX1A negative control primer targeting ORF-free intergenic DNA ( SA Biosciences ) was used ."], "relation": []}
{"trigger": ["The fold enrichment in site occupancy was calculated incorporating IgG control values and input DNA values using the ChampionChIP qPCR data analysis file ( SA Biosciences ) .", "The fold enrichment in site occupancy was calculated incorporating IgG control values and input DNA values using the ChampionChIP qPCR data analysis file ( SA Biosciences ) ."], "relation": []}
{"trigger": ["Quantification of cytokine levels .", "Quantification of cytokine levels ."], "relation": []}
{"trigger": ["<extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-5 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-6 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-13 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> secretion was assessed using fluorescent bead-based technology .", "IL-4 , IL-5 , IL-6 , IL-10 , IL-13 , IL-17 , and IFN-gamma <extra_id_0> secretion <extra_id_2> Localization <extra_id_1> was assessed using fluorescent bead-based technology ."], "relation": [["IL-4 , IL-5 , IL-6 , IL-10 , IL-13 , IL-17 , and IFN-gamma <extra_id_0> secretion <extra_id_2> Localization <extra_id_1> was assessed using fluorescent bead-based technology .", "<extra_id_0> IL-4 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> IL-5 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> IL-6 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> IL-13 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> secretion was assessed using fluorescent bead-based technology ."]]}
{"trigger": ["The Bio-Plex-hu Cytokine Panel , 17-Plex Group 1 was used according to the manufacturer 's instructions ( Bio-Rad Laboratories ) .", "The Bio-Plex-hu Cytokine Panel , 17-Plex Group 1 was used according to the manufacturer 's instructions ( Bio-Rad Laboratories ) ."], "relation": []}
{"trigger": ["Fluorescent signals were read and analyzed using the Bio-Plex 200 System ( Bio-Rad Laboratories ) .", "Fluorescent signals were read and analyzed using the Bio-Plex 200 System ( Bio-Rad Laboratories ) ."], "relation": []}
{"trigger": ["Online supplemental material .", "Online supplemental material ."], "relation": []}
{"trigger": ["Fig.S1 shows the induction of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> , <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> mRNA in human <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells after anti - <extra_id_0> CD2 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 3 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 28 <extra_id_2> Protein <extra_id_1> mAb and <extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> stimulation .", "Fig.S1 shows the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of RUNX1 , RUNX3 , and FOXP3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation ."], "relation": [["Fig.S1 shows the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of RUNX1 , RUNX3 , and FOXP3 mRNA in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation .", "Fig.S1 shows the induction of RUNX1 , RUNX3 , and FOXP3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_2> Theme <extra_id_1> mRNA <extra_id_2> Transcription <extra_id_2> Theme <extra_id_1> mRNA <extra_id_2> Transcription <extra_id_2> Theme <extra_id_1> in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation ."], ["Fig.S1 shows the induction of RUNX1 , RUNX3 , and FOXP3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation .", "Fig.S1 shows the induction of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> mRNA in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF-beta stimulation ."]]}
{"trigger": ["Fig.S2 shows decreased <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> mRNA and protein expression after siRNA - mediated knockdown and decreased <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> expression in human <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells after <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> knockdown .", "Fig.S2 shows <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> RUNX1 and RUNX3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> and protein expression after siRNA - <extra_id_0> mediated <extra_id_2> Positive_regulation <extra_id_1> <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> in human CD4 + T cells after RUNX1 and RUNX3 <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> ."], "relation": [["Fig.S2 shows <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased RUNX1 and RUNX3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_2> Theme <extra_id_1> mRNA <extra_id_2> Transcription <extra_id_2> Theme <extra_id_1> and protein expression after siRNA - mediated <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> decreased <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 <extra_id_0> mRNA <extra_id_2> Transcription <extra_id_1> and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - <extra_id_0> mediated <extra_id_2> Positive_regulation <extra_id_1> knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_2> Theme <extra_id_1> and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> in human CD4 + T cells after RUNX1 and RUNX3 knockdown ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> in human CD4 + T cells after RUNX1 and RUNX3 <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> knockdown <extra_id_2> Negative_regulation <extra_id_2> Cause <extra_id_1> ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> in human CD4 + T cells after RUNX1 and RUNX3 knockdown .", "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown ."], ["Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 <extra_id_0> knockdown <extra_id_2> Negative_regulation <extra_id_1> .", "Fig.S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> knockdown ."]]}
{"trigger": ["Fig.S3 shows the quantification of <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-5 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-10 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IL-13 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> levels in control siRNA transfected or <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> siRNA transfected human <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells .", "Fig.S3 shows the quantification of IL-4 , IL-5 , IL-10 , IL-13 , and IFN-gamma levels in control siRNA transfected or RUNX1 and RUNX3 <extra_id_0> siRNA <extra_id_2> Negative_regulation <extra_id_1> transfected human CD4 + T cells ."], "relation": [["Fig.S3 shows the quantification of IL-4 , IL-5 , IL-10 , IL-13 , and IFN-gamma levels in control siRNA transfected or RUNX1 and RUNX3 <extra_id_0> siRNA <extra_id_2> Negative_regulation <extra_id_1> transfected human CD4 + T cells .", "Fig.S3 shows the quantification of IL-4 , IL-5 , IL-10 , IL-13 , and IFN-gamma levels in control siRNA transfected or <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> siRNA transfected human CD4 + T cells ."]]}
{"trigger": ["Fig.S4 shows the putative RUNX binding sites in the <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> core promoter sequence of human , mouse , and rat .", "Fig.S4 shows the putative RUNX binding sites in the FOXP3 core promoter sequence of human , mouse , and rat ."], "relation": []}
{"trigger": ["Fig.S5 shows the induction of <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_1> protein after overexpression of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_1> in human <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells .", "Fig.S5 shows the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of FOXP3 protein after <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_1> of RUNX1 and RUNX3 in human CD4 + T cells ."], "relation": [["Fig.S5 shows the <extra_id_0> induction <extra_id_2> Positive_regulation <extra_id_1> of FOXP3 protein after overexpression of RUNX1 and RUNX3 in human CD4 + T cells .", "Fig.S5 shows the induction of <extra_id_0> FOXP3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> protein after <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_2> Cause <extra_id_1> overexpression <extra_id_2> Gene_expression <extra_id_2> Cause <extra_id_1> of RUNX1 and RUNX3 in human CD4 + T cells ."], ["Fig.S5 shows the induction of FOXP3 protein after <extra_id_0> overexpression <extra_id_2> Gene_expression <extra_id_1> of RUNX1 and RUNX3 in human CD4 + T cells .", "Fig.S5 shows the induction of FOXP3 protein after overexpression of <extra_id_0> RUNX1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> RUNX3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> in human CD4 + T cells ."]]}
{"trigger": ["Fig.S6 shows that endogenous <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> do not effect <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> expression in naive <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> + T cells of <extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> F / F <extra_id_0> CD4-cre <extra_id_2> Protein <extra_id_1> and <extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> F / F control mice , which were stimulated with anti - <extra_id_0> CD3 <extra_id_2> Protein <extra_id_1> and anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> mAbs , <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> and <extra_id_0> TGF-beta <extra_id_2> Protein <extra_id_1> in the absence or presence of anti - <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_1> and anti - <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_1> neutralizing mAbs .", "Fig.S6 shows that endogenous IL-4 and IFN-gamma do not <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> Foxp3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs ."], "relation": [["Fig.S6 shows that endogenous IL-4 and IFN-gamma do not <extra_id_0> effect <extra_id_2> Regulation <extra_id_1> Foxp3 expression in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs .", "Fig.S6 shows that endogenous <extra_id_0> IL-4 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> and <extra_id_0> IFN-gamma <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> do not effect Foxp3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs ."], ["Fig.S6 shows that endogenous IL-4 and IFN-gamma do not effect Foxp3 <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs .", "Fig.S6 shows that endogenous IL-4 and IFN-gamma do not effect <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> expression in naive CD4 + T cells of Cbfb F / F CD4-cre and Cbfb F / F control mice , which were stimulated with anti - CD3 and anti - CD28 mAbs , IL-2 and TGF-beta in the absence or presence of anti - IL-4 and anti - IFN-gamma neutralizing mAbs ."]]}
{"trigger": ["Fig.S7 shows similar cell death ( A ) and proliferation ( B ) of <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> + and <extra_id_0> Foxp3 <extra_id_2> Protein <extra_id_1> - cells in <extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> F / F <extra_id_0> CD4 <extra_id_2> Protein <extra_id_1> - <extra_id_0> cre <extra_id_2> Protein <extra_id_1> and <extra_id_0> Cbfb <extra_id_2> Protein <extra_id_1> F / F control mice cultures .", "Fig.S7 shows similar cell death ( A ) and proliferation ( B ) of Foxp3 + and Foxp3 - cells in Cbfb F / F CD4 - cre and Cbfb F / F control mice cultures ."], "relation": []}
{"trigger": ["Online supplemental material is available at http : / / www.jem.org / cgi / content / full / jem.20090596 / DC1 .", "Online supplemental material is available at http : / / www.jem.org / cgi / content / full / jem.20090596 / DC1 ."], "relation": []}
